Bufuralol is a new, non-selective -adrenoceptor blocking agent.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ceritinib | Bufuralol may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Bufuralol may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Bufuralol. |
| Amiodarone | The therapeutic efficacy of Bufuralol can be increased when used in combination with Amiodarone. |
| Bupivacaine | The serum concentration of Bupivacaine can be increased when it is combined with Bufuralol. |
| Dipyridamole | Dipyridamole may increase the bradycardic activities of Bufuralol. |
| Disopyramide | Disopyramide may increase the bradycardic activities of Bufuralol. |
| Dronedarone | Dronedarone may increase the bradycardic activities of Bufuralol. |
| Fingolimod | Bufuralol may increase the bradycardic activities of Fingolimod. |
| Floctafenine | The risk or severity of adverse effects can be increased when Bufuralol is combined with Floctafenine. |
| Mepivacaine | The serum concentration of Mepivacaine can be increased when it is combined with Bufuralol. |
| Methacholine | Bufuralol may increase the bronchoconstrictory activities of Methacholine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with Bufuralol. |
| Nifedipine | The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Bufuralol. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Bufuralol. |
| Regorafenib | Regorafenib may increase the bradycardic activities of Bufuralol. |
| Reserpine | Reserpine may increase the hypotensive activities of Bufuralol. |
| Deserpidine | Deserpidine may increase the hypotensive activities of Bufuralol. |
| Guanethidine | Guanethidine may increase the hypotensive activities of Bufuralol. |
| Rivastigmine | Bufuralol may increase the bradycardic activities of Rivastigmine. |
| Mirabegron | The serum concentration of Bufuralol can be increased when it is combined with Mirabegron. |
| Insulin argine | Bufuralol may increase the hypoglycemic activities of Insulin argine. |
| Nicotine | The risk or severity of adverse effects can be increased when Bufuralol is combined with Nicotine. |
| Cevimeline | The risk or severity of adverse effects can be increased when Bufuralol is combined with Cevimeline. |
| Carbamoylcholine | The risk or severity of adverse effects can be increased when Bufuralol is combined with Carbamoylcholine. |
| Bethanechol | The risk or severity of adverse effects can be increased when Bufuralol is combined with Bethanechol. |
| Pilocarpine | The risk or severity of adverse effects can be increased when Bufuralol is combined with Pilocarpine. |
| Varenicline | The risk or severity of adverse effects can be increased when Bufuralol is combined with Varenicline. |
| Acetylcholine | The risk or severity of adverse effects can be increased when Bufuralol is combined with Acetylcholine. |
| Arecoline | The risk or severity of adverse effects can be increased when Bufuralol is combined with Arecoline. |
| Lobeline | The risk or severity of adverse effects can be increased when Bufuralol is combined with Lobeline. |
| NGX267 | The risk or severity of adverse effects can be increased when Bufuralol is combined with NGX267. |
| GTS-21 | The risk or severity of adverse effects can be increased when Bufuralol is combined with GTS-21. |
| Epibatidine | The risk or severity of adverse effects can be increased when Bufuralol is combined with Epibatidine. |
| Xanomeline | The risk or severity of adverse effects can be increased when Bufuralol is combined with Xanomeline. |
| Thiethylperazine | The serum concentration of Bufuralol can be increased when it is combined with Thiethylperazine. |
| Promazine | The serum concentration of Bufuralol can be increased when it is combined with Promazine. |
| Prochlorperazine | The serum concentration of Bufuralol can be increased when it is combined with Prochlorperazine. |
| Triflupromazine | The serum concentration of Bufuralol can be increased when it is combined with Triflupromazine. |
| Fluphenazine | The serum concentration of Bufuralol can be increased when it is combined with Fluphenazine. |
| Moricizine | The serum concentration of Bufuralol can be increased when it is combined with Moricizine. |
| Trifluoperazine | The serum concentration of Bufuralol can be increased when it is combined with Trifluoperazine. |
| Perphenazine | The serum concentration of Bufuralol can be increased when it is combined with Perphenazine. |
| Mesoridazine | The serum concentration of Bufuralol can be increased when it is combined with Mesoridazine. |
| Acetophenazine | The serum concentration of Bufuralol can be increased when it is combined with Acetophenazine. |
| Promethazine | The serum concentration of Bufuralol can be increased when it is combined with Promethazine. |
| Alimemazine | The serum concentration of Bufuralol can be increased when it is combined with Alimemazine. |
| Periciazine | The serum concentration of Bufuralol can be increased when it is combined with Periciazine. |
| Acepromazine | The serum concentration of Bufuralol can be increased when it is combined with Acepromazine. |
| Aceprometazine | The serum concentration of Bufuralol can be increased when it is combined with Aceprometazine. |
| Pipotiazine | The serum concentration of Bufuralol can be increased when it is combined with Pipotiazine. |
| Thioproperazine | The serum concentration of Bufuralol can be increased when it is combined with Thioproperazine. |
| BL-1020 | The serum concentration of Bufuralol can be increased when it is combined with BL-1020. |
| Cyamemazine | The serum concentration of Bufuralol can be increased when it is combined with Cyamemazine. |
| Methylene blue | The serum concentration of Bufuralol can be increased when it is combined with Methylene blue. |
| Propiopromazine | The serum concentration of Bufuralol can be increased when it is combined with Propiopromazine. |
| Perazine | The serum concentration of Bufuralol can be increased when it is combined with Perazine. |
| Butaperazine | The serum concentration of Bufuralol can be increased when it is combined with Butaperazine. |
| Chlorproethazine | The serum concentration of Bufuralol can be increased when it is combined with Chlorproethazine. |
| Thiazinam | The serum concentration of Bufuralol can be increased when it is combined with Thiazinam. |
| Dixyrazine | The serum concentration of Bufuralol can be increased when it is combined with Dixyrazine. |
| Perphenazine enanthate | The serum concentration of Bufuralol can be increased when it is combined with Perphenazine enanthate. |
| Digoxin | Bufuralol may increase the bradycardic activities of Digoxin. |
| Acetyldigitoxin | Bufuralol may increase the bradycardic activities of Acetyldigitoxin. |
| Deslanoside | Bufuralol may increase the bradycardic activities of Deslanoside. |
| Ouabain | Bufuralol may increase the bradycardic activities of Ouabain. |
| Digitoxin | Bufuralol may increase the bradycardic activities of Digitoxin. |
| Oleandrin | Bufuralol may increase the bradycardic activities of Oleandrin. |
| Cymarin | Bufuralol may increase the bradycardic activities of Cymarin. |
| Proscillaridin | Bufuralol may increase the bradycardic activities of Proscillaridin. |
| Metildigoxin | Bufuralol may increase the bradycardic activities of Metildigoxin. |
| Lanatoside C | Bufuralol may increase the bradycardic activities of Lanatoside C. |
| Gitoformate | Bufuralol may increase the bradycardic activities of Gitoformate. |
| Acetyldigoxin | Bufuralol may increase the bradycardic activities of Acetyldigoxin. |
| Peruvoside | Bufuralol may increase the bradycardic activities of Peruvoside. |
| Lidocaine | The serum concentration of Lidocaine can be increased when it is combined with Bufuralol. |
| Icosapent | Icosapent may decrease the antihypertensive activities of Bufuralol. |
| Mesalazine | The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Bufuralol. |
| Indomethacin | Indomethacin may decrease the antihypertensive activities of Bufuralol. |
| Nabumetone | Nabumetone may decrease the antihypertensive activities of Bufuralol. |
| Ketorolac | Ketorolac may decrease the antihypertensive activities of Bufuralol. |
| Tenoxicam | Tenoxicam may decrease the antihypertensive activities of Bufuralol. |
| Celecoxib | Celecoxib may decrease the antihypertensive activities of Bufuralol. |
| Tolmetin | Tolmetin may decrease the antihypertensive activities of Bufuralol. |
| Rofecoxib | Rofecoxib may decrease the antihypertensive activities of Bufuralol. |
| Piroxicam | Piroxicam may decrease the antihypertensive activities of Bufuralol. |
| Fenoprofen | Fenoprofen may decrease the antihypertensive activities of Bufuralol. |
| Valdecoxib | Valdecoxib may decrease the antihypertensive activities of Bufuralol. |
| Diclofenac | Diclofenac may decrease the antihypertensive activities of Bufuralol. |
| Sulindac | Sulindac may decrease the antihypertensive activities of Bufuralol. |
| Flurbiprofen | Flurbiprofen may decrease the antihypertensive activities of Bufuralol. |
| Etodolac | Etodolac may decrease the antihypertensive activities of Bufuralol. |
| Mefenamic acid | Mefenamic acid may decrease the antihypertensive activities of Bufuralol. |
| Naproxen | Naproxen may decrease the antihypertensive activities of Bufuralol. |
| Sulfasalazine | Sulfasalazine may decrease the antihypertensive activities of Bufuralol. |
| Phenylbutazone | Phenylbutazone may decrease the antihypertensive activities of Bufuralol. |
| Meloxicam | Meloxicam may decrease the antihypertensive activities of Bufuralol. |
| Carprofen | Carprofen may decrease the antihypertensive activities of Bufuralol. |
| Diflunisal | Diflunisal may decrease the antihypertensive activities of Bufuralol. |
| Salicylic acid | Salicylic acid may decrease the antihypertensive activities of Bufuralol. |